Insider Transactions Reported by 18 Insiders of REGENXBIO Inc.

Symbol
RGNX on Nasdaq
Location
Rockville, MD

Insiders trading volume in the past year

REGENXBIO Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Allan M. Fox Director $23,125,113 30 May 2025
Mills Kenneth T. Director $6,518,842 -$163,046 -2.4% 27 Jan 2026
Curran Simpson Chief Executive Officer, Director $4,931,559 -$416,598 -7.8% 06 Jan 2026
Steve Pakola Chief Medical Officer $2,566,034 -$53,033 -2% 10 Mar 2026
Patrick J. Christmas Chief Strategy & Legal Officer $2,351,043 01 Feb 2026
Mitchell Chan Chief Financial Officer $1,839,137 06 Jan 2026
Olivier Danos Chief Scientific Officer $1,826,628 01 Feb 2025
Craig Malzahn Chief Technology Officer $1,183,601 06 Jan 2026
Vittal Vasista Chief Financial Officer $926,968 19 Mar 2024
Jennifer Zachary Director $175,850 30 May 2025
Jean Bennett Director $151,860 30 May 2025
Argeris N. Karabelas Director $151,860 30 May 2025
Daniel Tasse Director $151,860 30 May 2025
Alexandra Glucksmann Director $151,860 30 May 2025
David C. Stump Director $151,860 30 May 2025
George Migausky V Director $151,860 30 May 2025
Luke M. Beshar Director 04 Jun 2021
Daniel Abdun-Nabi Director 04 Jun 2021

Recent Insider Transactions by Companies or Individuals for REGENXBIO Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Steve Pakola RGNX Common Stock Sale -2.02% $53,033 $10.35 -5,124 247,926 10 Mar 2026 Direct
Steve Pakola RGNX Common Stock Tax liability -2.04% -5,267 253,050 01 Feb 2026 Direct
Patrick J. Christmas RGNX Common Stock Tax liability -2.18% -4,700 210,667 01 Feb 2026 Direct
Mills Kenneth T. RGNX Common Stock Tax liability -31.3% -221,753 486,118 27 Jan 2026 Direct
Mills Kenneth T. RGNX Common Stock Options Exercise 46.6% 225,000 707,871 27 Jan 2026 Direct
Mills Kenneth T. RGNX Stock Options (Right to Buy) Options Exercise -50% -225,000 225,000 27 Jan 2026 Direct
Steve Pakola RGNX Common Stock Award 34.2% 65,847 258,317 06 Jan 2026 Direct
Steve Pakola RGNX Stock Options (Right to buy) Award 35,402 35,402 06 Jan 2026 Direct
Craig Malzahn RGNX Common Stock Award 402.8% 65,847 82,194 06 Jan 2026 Direct
Craig Malzahn RGNX Stock Options (Right to buy) Award 35,402 35,402 06 Jan 2026 Direct
Curran Simpson RGNX Common Stock Award 73.3% 144,864 342,467 06 Jan 2026 Direct
Curran Simpson RGNX Stock Options (Right to buy) Award 233,651 233,651 06 Jan 2026 Direct
Patrick J. Christmas RGNX Common Stock Award 52.1% 73,749 215,367 06 Jan 2026 Direct
Patrick J. Christmas RGNX Stock Options (Right to buy) Award 39,650 39,650 06 Jan 2026 Direct
Mitchell Chan RGNX Common Stock Award 136.6% 73,749 127,717 06 Jan 2026 Direct
Mitchell Chan RGNX Stock Options (Right to buy) Award 39,650 39,650 06 Jan 2026 Direct
Curran Simpson RGNX Common Stock Tax liability -8.59% -18,559 197,603 02 Jan 2026 Direct
Craig Malzahn RGNX Common Stock Tax liability -7.04% -1,238 16,347 02 Jan 2026 Direct
Patrick J. Christmas RGNX Common Stock Tax liability -6.47% -9,793 141,618 02 Jan 2026 Direct
Steve Pakola RGNX Common Stock Tax liability -8.66% -18,247 192,470 02 Jan 2026 Direct
Curran Simpson RGNX Common Stock Sale -8.78% $262,635 $12.62 -20,811 216,162 09 Oct 2025 Direct
Curran Simpson RGNX Common Stock Sale -3.12% $76,469 $10.03 -7,624 236,973 29 Sep 2025 Direct
Curran Simpson RGNX Common Stock Sale -3.07% $77,495 $10.02 -7,734 244,597 10 Sep 2025 Direct
Craig Malzahn RGNX Common Stock Tax liability -1.31% -234 17,585 01 Sep 2025 Direct
Mitchell Chan RGNX Common Stock Tax liability -8.33% -4,901 53,968 01 Sep 2025 Direct
Patrick J. Christmas RGNX Common Stock Tax liability -3.01% -4,699 151,411 01 Aug 2025 Direct
Curran Simpson RGNX Common Stock Tax liability -1.83% -4,701 252,331 01 Jul 2025 Direct
Allan M. Fox RGNX Common Stock Award 68.8% 7,768 19,054 30 May 2025 Direct
Allan M. Fox RGNX Stock Options (Right to Buy) Award 39,815 39,815 30 May 2025 Direct
Jennifer Zachary RGNX Common Stock Award 54.3% 7,768 22,064 30 May 2025 Direct
Jennifer Zachary RGNX Stock Options (Right to Buy) Award 39,815 39,815 30 May 2025 Direct
Daniel Tasse RGNX Common Stock Award 68.8% 7,768 19,054 30 May 2025 Direct
Daniel Tasse RGNX Stock Options (Right to Buy) Award 39,815 39,815 30 May 2025 Direct
David C. Stump RGNX Common Stock Award 68.8% 7,768 19,054 30 May 2025 Direct
David C. Stump RGNX Stock Options (Right to Buy) Award 39,815 39,815 30 May 2025 Direct
Mills Kenneth T. RGNX Common Stock Award 1.64% 7,768 482,871 30 May 2025 Direct
Mills Kenneth T. RGNX Stock Options (Right to Buy) Award 39,815 39,815 30 May 2025 Direct
George Migausky V RGNX Common Stock Award 68.8% 7,768 19,054 30 May 2025 Direct
George Migausky V RGNX Stock Options (Right to Buy) Award 39,815 39,815 30 May 2025 Direct
Alexandra Glucksmann RGNX Common Stock Award 68.8% 7,768 19,054 30 May 2025 Direct
Alexandra Glucksmann RGNX Stock Options (Right to Buy) Award 39,815 39,815 30 May 2025 Direct
Argeris N. Karabelas RGNX Common Stock Award 68.8% 7,768 19,054 30 May 2025 Direct
Argeris N. Karabelas RGNX Stock Options (Right to Buy) Award 39,815 39,815 30 May 2025 Direct
Jean Bennett RGNX Common Stock Award 68.8% 7,768 19,054 30 May 2025 Direct
Jean Bennett RGNX Stock Options (Right to Buy) Award 39,815 39,815 30 May 2025 Direct
Mills Kenneth T. RGNX Common Stock Sale -4.16% $163,046 $7.91 -20,602 475,103 12 May 2025 Direct
Mills Kenneth T. RGNX Common Stock Options Exercise 4.34% 20,602 495,705 12 May 2025 Direct
Mills Kenneth T. RGNX Stock Options (Right to Buy) Options Exercise -100% -20,602 0 12 May 2025 Direct
Mills Kenneth T. RGNX Common Stock Options Exercise 6.92% 30,752 475,103 27 Mar 2025 Direct
Mills Kenneth T. RGNX Stock Options (Right to Buy) Options Exercise -59.9% -30,752 20,602 27 Mar 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.